Dr Zachariah P Zachariah, arguably the most influential Indian- American Republican, a a major fund-raiser for the party for more than two decades and a close friend of the Bush family, has been......
While companies continue to face regulatory pressure leading to higher costs, they see an uptick from the launch of differentiated and high-margin products. Illustration: Uttam Ghosh/Rediff.com......
After spending considerable time and energy in remediation efforts in the wake of the US Food and Drug Administration's warning letter on compliance issues, the company's leadership has finally set......
No new capacity addition is planned for 2018 and capital expenditure plans are on hold Indian companies raised 40 per cent less in foreign currency loans this year till date at $13.5 billion......
Sun Pharma and Dr Reddy's top list in terms of those who face most class-action litigation. The number of class action lawsuits filed against Indian pharmaceutical companies has gone up in recent......
One reason Japan is betting highly on Indian pharma is that these companies have strong cash flows, low leverage and high debt capacity for medium to large sized acquisitions, report Sohini Das &......